Background and activities
Rector is the head of NTNU's academic and administrative activities.
- Specialist in neurology
2009–2013 Chief Executive Officer, Central Norway Regional Health Authority
2006–2009 Chief Executive Officer, St. Olavs Hospital
2005– Vice Chief Executive, St. Olavs Hospital
2001–2003 Board member, Central Norway Regional Health Authority
1999–2005 Dean, Faculty of Medicine (NTNU)
1996–1998 Vice Dean, Faculty of Medicine (NTNU)
1998–1999 Head of the Norwegian Neurological Association
1998– Chief physician and Professor of neurology, Faculty of Medicine, NTNU
1993– Dr.med. in neurology, University of Trondheim (now NTNU)
1985– Cand.med., University of Bergen
Appointments and awards
Bovim has served on national and international committees and advisory boards on topics such as education, research, medicine and the health sector, including:
- Member and head of the board of directors for the Research Council of Norway’s Division for Health and Society
- Norwegian delegate to the Association of Nordic Research Council Association
- Norwegian delegate to European Medical Research Council
- Recipient of the Norwegian Migraine Society’s 1993 research prize
Scientific, academic and artistic work
A selection of recent journal publications, artistic productions, books, including book and report excerpts.
Scientific, academic and artistic work
A selection of recent journal publications, artistic productions, books, including book and report excerpts. See all publications in the database
- (2011) Headache and migraine during pregnancy and puerperium: the MIGRA-study. The Journal of Headache and Pain. vol. 12 (4).
- (2010) The EEG response to photic stimulation is not increased in alcohol-related seizures. Clinical Neurophysiology. vol. 121 (11).
- (2010) Quantitative EEG in Patients With Alcohol-Related Seizures. Alcoholism: Clinical and Experimental Research. vol. 34 (10).
- (2009) Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache. Cephalalgia. vol. 29 (3).
- (2008) Cerebrospinal fluid cytokine levels in migraine, tension-type headache, and cervicogenic headache. Cephalalgia. vol. 29.
- (2008) Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients. BMC Neurology. vol. 26 (8).
- (2007) Migraine aura or transient ischemic attacks? A five-year follow-up case-control study of women with transient central nervous system disorders in pregnancy. BMC Medicine. vol. 17 (5).
- (2006) Sickness absence is related to headache frequency. The HUNT Study. The Journal of Headache and Pain. vol. 7.
- (2006) Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients. The Journal of Headache and Pain. vol. 7.
- (2006) Sick leave is related to frequencies of migraine and non-migrainous headache - The HUNT study. Cephalalgia. vol. 26.
- (2006) Involvement of the renin-angiotensin system in migraine. Journal of Hypertension. vol. 24 (1).
- (2005) Headache after whiplash is likely to represent stress-induced primary headache. Cephalalgia. vol. 25.
- (2005) Headache and transient focal neurological symptoms during pregnancy, a prospective cohort. Acta Neurologica Scandinavica. vol. 111.
- (2005) Do high TSH values protect against chronic musculoskeletal complaints? The Nord-Trondelag Health Study (HUNT). Pain. vol. 113.
- (2005) Does hypertension protect against chronic musculoskeletal complaints? The Nord-Trøndelag Healt Study. Archives of Internal Medicine. vol. 165.
- (2005) Low socioeconomic status is associated with chronic musculoskeletal complaints among 46,901 adults in Norway. Scandinavian Journal of Public Health. vol. 33.
- (2005) A structured, nurse-led intervention program improves quality of life in patients with epilepsy: A ramdomized, controlled trial. Epilepsy & Behavior. vol. 7.
- (2005) ACE inhibitors and AT(1) receptor blockers. Cephalalgia. vol. 25.
- (2004) A Structured nurse intervention programme improves quality of life in patients with epilepsy. A randomised controlled study. Epilepsia. vol. 45.
- (2004) ACE inhibitors and AT1 receptor Blockers. 7th EHF congress, Program and abstract book.